MetaCap

Astrotech Corporation (DE) (ASTC)

NASDAQ: ASTCIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

3.50-0.03 (-0.85%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ASTC stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$7.88
52-week range
1.92 – 68.85
Day range
3.40 – 3.70
Volume / Avg
29.61K / 30.46K
Beta
—

52-week range

$1.92$68.85

ASTC stock today

Shares of Astrotech (DE) (ASTC) finished lower on Nov 20 at $3.50, a drop of 0.85% or $0.03 per share, versus the S&P 500's 3.70% decline. Shares are 94.9% below their 52-week high of $68.85, set on May 29, 2026 and 82.3% above the 52-week low of $1.92, near the bottom of the past year's range. ASTC is up 1.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 28.2%.

Astrotech (DE) has posted a net loss over the last twelve months (EPS of -$7.88), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Astrotech (DE)

Company profile

Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, and law enforcement centers.

Industry
Biotechnology: Laboratory Analytical Instruments
CEO
Mr. Thomas Boone Pickens III
Headquarters
Austin, TX

Financial highlights

Full financials

In fiscal 2026, Astrotech (DE) generated $913,000 in revenue, down 8.7% from fiscal 2025, its first annual decline since 2025. Astrotech (DE) reported a net loss of $14.4 million, compared with a loss of $13.8 million a year earlier. Gross margin was 23.8% (down from 47.5%) and operating margin -1548.5%.

Astrotech (DE) annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$913.00K$1.00M$1.70M$750.00K$869.00K
Growth-8.70%-41.18%+126.67%-13.69%+160.18%
Net income$-14.43M$-13.85M$-11.67M$-9.64M$-8.33M
EPS (diluted)—————

Earnings

Earnings history
Last reported (Sep/2026)
Nov 13, 2026
EPS actual vs est.
$-1.46 vs —

ASTC news

All ASTC news

Astrotech (DE) peers

Industrials sector
ASTC peer companies
CompanyPrice% ChgMarket capCompare
BNGOBionano Genomics Inc.0.8222-7.11%$11.50Mvs ASTC
CIRCCircle8 Group Inc.0.1361-12.25%$15.99Mvs ASTC
EYPTEyePoint Inc.0.2342-11.36%$26.65Mvs ASTC
PRPOPrecipio Inc.17.35-6.17%$31.11Mvs ASTC
RPIDRapid Micro Biosystems Inc. Class A0.735-0.04%$37.37Mvs ASTC
HBIOHarvard Bioscience Inc.8.66-0.23%$39.60Mvs ASTC
SEERSeer Inc. Class A1.36-1.81%$75.91Mvs ASTC
QTRXQuanterix Corporation1.96-3.45%$93.06Mvs ASTC

Indexes, lists and sector

Astrotech (DE) stock FAQ

What is Astrotech (DE)'s stock price today?

ASTC last traded at $3.50 as of Nov 20, 4:00 PM EST, down 0.85% on the day. Prices are delayed at least 15 minutes.

Does Astrotech (DE) pay a dividend?

No. Astrotech (DE) does not currently pay a regular cash dividend.

Who is Astrotech (DE)'s CEO?

Mr. Thomas Boone Pickens III is the chief executive officer of Astrotech Corporation (DE).

Has ASTC ever split its stock?

Yes. The most recent ASTC stock split was a 1-for-30 split on Dec 5, 2022, one of 3 splits on record.

What is the ASTC 52-week high?

The 52-week high for ASTC is $68.85 and the 52-week low is $1.92. The stock is currently 94.9% below its high.

Compare ASTC